Gastrointestinal · PANCE / PANRE

Upper and Lower GI Bleeding (Approach and Management)

Bleeding proximal vs distal to the ligament of Treitz — resuscitate first, localize next, then targeted endoscopic or angiographic therapy.

Also known as: GI bleed, upper GI bleed, UGIB, lower GI bleed, LGIB, hematemesis, melena, hematochezia

Overview

Acute or chronic blood loss from the gastrointestinal tract. Upper GI bleeding (UGIB) originates proximal to the ligament of Treitz and presents most commonly with hematemesis, coffee-ground emesis, or melena. Lower GI bleeding (LGIB) originates distal to the ligament of Treitz and most commonly presents as hematochezia or maroon stool. Obscure GI bleeding refers to bleeding with negative initial upper and lower endoscopy.

Epidemiology

UGIB: ~100 per 100,000 adults per year; mortality 2-10%. Peptic ulcer disease accounts for ~30-50% of UGIB, variceal bleeding ~10-20%. LGIB: ~20-30 per 100,000 per year; diverticular bleeding is the most common cause in adults (30-50%), followed by angiodysplasia, colitis (ischemic, infectious, IBD), neoplasm, and hemorrhoids. Both are more common in older adults and patients on antiplatelets/anticoagulants.

Try two board-style Upper and Lower GI Bleeding questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1GastrointestinalMedium
A 55-year-old male has an upper GI bleed. Esophagogastroduodenoscopy (EGD) shows a duodenal ulcer with a visible vessel (Forrest IIa). IV proton pump inhibitor (PPI) is started. Which of the following is the most appropriate next step in endoscopic management?
  • AEndoscopic injection sclerotherapy
  • BHemostatic clip plus epinephrine injection
  • CTopical hemostatic powder application
  • DArgon plasma coagulation monotherapy
Reveal answer & full explanation
Correct answer: B — Hemostatic clip plus epinephrine injection
  • AEndoscopic injection sclerotherapy
  • BHemostatic clip plus epinephrine injection
  • CTopical hemostatic powder application
  • DArgon plasma coagulation monotherapy

Why Hemostatic clip plus epinephrine injection is correct

  • Forrest IIa (non-bleeding visible vessel) is a high-risk stigma that requires endoscopic hemostasis.
  • Combination therapy — epinephrine injection plus a second modality such as a hemostatic clip or thermal coagulation — is superior to epinephrine injection alone.
  • Epinephrine alone is inadequate; the mechanical/thermal component provides durable hemostasis of the vessel.

Why the others are wrong

  • Endoscopic injection sclerotherapy — a technique for esophageal/gastric varices, not bleeding peptic ulcers (right-concept-wrong-lesion).
  • Topical hemostatic powder application — a temporizing rescue measure that sloughs off the mucosa within 24-72 hours; it does not durably obliterate an exposed visible vessel (right-concept-wrong-durability).
  • Argon plasma coagulation monotherapy — thermal monotherapy that is less durable for a visible vessel than dual therapy (single-modality trap).

Additional high-yield points

  • Post-endoscopy proton pump inhibitor (PPI): IV infusion (80 mg bolus then 8 mg/hr for 72 hours) reduces rebleeding and mortality; transition to oral PPI BID after 72 hours.
  • H. pylori testing and eradication is mandatory in all peptic ulcer disease (PUD); eradication reduces recurrence from ~80% to <10%.
Question 2GastrointestinalMedium
A 71-year-old man is brought to the emergency department after two episodes of coffee-ground emesis followed by a black, tarry stool. He reports several weeks of epigastric burning. He has osteoarthritis of both knees, for which he takes high-dose ibuprofen most days, and mild diet-controlled type 2 diabetes. He drinks one beer on weekends and does not smoke. On exam he is pale; heart rate is 104/min and blood pressure is 118/72 mm Hg. Stool is melenic on rectal exam, and the BUN:creatinine ratio is 38. Of the elements in his history, which of the following is the strongest risk factor for his upper gastrointestinal bleed?
  • AChronic osteoarthritis pain
  • BType 2 diabetes mellitus
  • CDaily high-dose NSAID use
  • DAdvanced age over 70 years
Reveal answer & full explanation
Correct answer: C — Daily high-dose NSAID use
  • AChronic osteoarthritis pain
  • BType 2 diabetes mellitus
  • CDaily high-dose NSAID use
  • DAdvanced age over 70 years

Why Daily high-dose NSAID use is correct

  • Peptic ulcer disease causes 30-50% of upper GI bleeds, and chronic NSAID/aspirin use is the dominant modifiable driver: NSAIDs inhibit COX-1-mediated prostaglandin synthesis, stripping the gastroduodenal mucosa of its protective mucus/bicarbonate layer and promoting acid-peptic erosion of submucosal vessels.
  • This patient's high-dose daily ibuprofen, antecedent epigastric burning, melena, and BUN:Cr ratio greater than 30 all point to an NSAID-related bleeding ulcer.
  • Guideline management (ACG 2021) is IV PPI, EGD within 24 hours with endoscopic hemostasis for high-risk stigmata, H. pylori testing/eradication, and NSAID avoidance.

Why the others are wrong

  • Type 2 diabetes mellitus is a comorbidity that can worsen outcomes but is not an established independent risk factor for upper GI bleeding; it does not erode mucosa.
  • Chronic osteoarthritis pain — the arthritis is the indication for treatment rather than the exposure that injures the gut; the mucosal damage comes from COX-1 inhibition by the ibuprofen taken for it, so the drug and not the pain is the risk factor.
  • Advanced age over 70 years is a real but comparatively weak, non-modifiable risk factor; it amplifies risk mainly through accumulated comorbidity and antithrombotic use rather than directly causing the lesion.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Upper and Lower GI Bleeding (Approach and Management) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • UGIB: NSAID/aspirin use, H. pylori, anticoagulants, chronic liver disease/portal hypertension (varices), prior PUD, severe physiologic stress (ICU), alcohol use, smoking
  • LGIB: diverticulosis, prior radiation, NSAID use, anticoagulants, vascular disease (mesenteric ischemia), IBD, recent polypectomy or endoscopy, colorectal cancer, hemorrhoids
  • Both: age >65, antithrombotic therapy, chronic kidney disease, coagulopathy

Pathophysiology

Bleeding sources reflect underlying mechanisms: erosion of a vessel by acid-peptic injury (PUD), rupture of submucosal varices in portal hypertension, Mallory-Weiss tears, vascular malformations (angiodysplasia, Dieulafoy), diverticular vessel erosion (LGIB), inflammatory or neoplastic ulceration, ischemic injury, and post-procedural bleeding. Hemodynamic compromise depends on volume and rate of bleeding plus patient reserve.

Clinical presentation

Symptoms

  • Hematemesis (bright red or coffee-ground) — UGIB
  • Melena (black, tarry, foul-smelling stool) — usually UGIB, occasionally right-sided LGIB if slow
  • Hematochezia (bright red blood per rectum) — usually LGIB, but brisk UGIB can also produce hematochezia
  • Maroon stool — distal small bowel or proximal colon
  • Lightheadedness, syncope, dyspnea, fatigue from anemia
  • Pre-syncope, exertional intolerance with chronic bleeding

Signs / physical exam

  • Tachycardia, orthostatic hypotension (~15% blood loss), frank hypotension (~30% loss)
  • Pallor, cool/clammy skin
  • Abdominal tenderness suggests inflammation, ischemia, or perforation (rare in pure UGIB/LGIB)
  • Stigmata of chronic liver disease (spider angiomata, palmar erythema, caput medusae, ascites)
  • DRE: gross blood, melena, palpable mass

Classic findings

BUN:Creatinine ratio >30 (in absence of CKD) strongly suggests upper GI source from absorbed blood proteins; orthostatic vital signs help estimate volume loss.

Differential diagnosis

  • Upper GI bleed: peptic ulcer disease — NSAID use, H. pylori, epigastric pain, melena ± hematemesis; treat with PPI and EGD
  • Upper GI bleed: variceal hemorrhage — Cirrhosis or portal hypertension; large-volume hematemesis; octreotide + band ligation + antibiotics
  • Upper GI bleed: Mallory-Weiss tear — Vomiting then hematemesis; usually self-limited
  • Upper GI bleed: erosive gastritis/esophagitis — Acute illness, NSAIDs, alcohol; diffuse mucosal injury
  • Upper GI bleed: Dieulafoy lesion — Submucosal artery, often gastric fundus; recurrent painless bleeding
  • Upper GI bleed: aortoenteric fistula — History of aortic graft or AAA; herald sentinel bleed precedes massive hemorrhage
  • Upper GI bleed: malignancy (esophageal, gastric) — Weight loss, anemia, chronic blood loss
  • Lower GI bleed: diverticular bleeding — Painless brisk hematochezia in elderly; usually right-sided; stops spontaneously in 75%
  • Lower GI bleed: angiodysplasia — Painless intermittent bleeding; older adults, CKD, aortic stenosis; right colon
  • Lower GI bleed: colitis (ischemic, infectious, IBD) — Diarrhea, abdominal pain, fever; mucosal inflammation on endoscopy
  • Lower GI bleed: colorectal neoplasm — Chronic occult or overt bleeding, weight loss, change in bowel habits
  • Lower GI bleed: hemorrhoidal/anorectal — Bright red on toilet paper, painless (internal) or painful (thrombosed external)

Diagnostic workup

Labs

  • CBC (initial Hgb may not reflect acute loss until reequilibration), BMP (BUN/Cr ratio), LFTs, coagulation studies (PT/INR, PTT), type and crossmatch ≥2 units
  • Lactate if hemodynamically unstable
  • Pregnancy test in women of reproductive age
  • Stool studies if infectious colitis suspected

Imaging

  • Upper endoscopy (EGD): within 24 h for UGIB (within 12 h if hemodynamically unstable or variceal suspicion)
  • Colonoscopy: after adequate bowel preparation for LGIB; ideally within 24 h once stabilized
  • CT angiography: for active brisk bleeding, especially when endoscopy is nondiagnostic or impractical; localizes bleeding ≥0.3-0.5 mL/min
  • Tagged RBC scan: detects slower bleeding (~0.1 mL/min) but less precise for localization
  • Conventional angiography with embolization: therapeutic for arterial bleeding when endoscopy fails or patient unstable
  • Push enteroscopy, video capsule endoscopy, or deep enteroscopy (single/double balloon) for obscure or small bowel sources
  • Meckel scan (technetium pertechnetate) in young patients with obscure bleeding

Diagnostic algorithm

flowchart TD
  A[Suspected GI bleed] --> B[ABCs + 2 large-bore IVs<br/>type and cross, labs, NPO]
  B --> C[Resuscitate with crystalloid<br/>transfuse to Hgb ≥7 g/dL<br/>correct coagulopathy / reverse anticoagulant]
  C --> D{Upper vs lower source?<br/>Hematemesis, melena, BUN:Cr >30 = upper}
  D -->|Upper| E[IV PPI<br/>± octreotide + ceftriaxone if variceal]
  E --> F[EGD within 12-24 h<br/>endoscopic hemostasis<br/>combination therapy for high-risk stigmata]
  F --> G{Hemostasis<br/>achieved?}
  G -->|No| H[Angiographic embolization<br/>or surgery; TIPS for varices]
  G -->|Yes| I[H. pylori test, PPI,<br/>NSAID counseling, beta-blocker if varices]
  D -->|Lower stable| J[Rapid bowel prep<br/>+ colonoscopy ≤24 h]
  J --> K[Endoscopic therapy<br/>treat underlying cause]
  D -->|Lower unstable / brisk hematochezia| L[CTA → angiography<br/>with embolization]
  L --> M{Failed?}
  M -->|Yes| N[Surgical resection<br/>subtotal colectomy if source unknown]
Unified approach to acute upper and lower GI bleeding.

Complications

  • Hemorrhagic shock and multiorgan failure
  • Aspiration pneumonia
  • Rebleeding (UGIB rebleed ~10-20% depending on lesion)
  • Myocardial infarction from demand ischemia
  • Acute kidney injury
  • Transfusion-related reactions, TACO, TRALI
  • Hospital-acquired infections
  • Death (overall mortality 2-10% UGIB, 2-4% LGIB; higher with variceal hemorrhage and comorbidities)

PANCE pearls

  • Resuscitate first, localize later — fluid + blood + correct coagulopathy before endoscopy whenever possible.
  • BUN:Cr >30 (without CKD) points to an upper source; do NG lavage only if needed for visualization, not for diagnosis.
  • Brisk upper GI bleeding (massive) can present as hematochezia — get EGD first when in doubt with hemodynamic instability.
  • Variceal bleed cocktail: octreotide + ceftriaxone + early EGD with band ligation; consider TIPS for refractory bleeding.
  • Restrictive transfusion (target Hgb ≥7) improves outcomes in stable UGIB; do not over-transfuse variceal patients (raises portal pressure and worsens bleeding).

References

  • ACG 2021 UGIB — ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (Laine et al., Am J Gastroenterol 2021)
  • ACG 2023 LGIB — ACG Clinical Guideline: Management of Patients with Acute Lower Gastrointestinal Bleeding (Sengupta et al., Am J Gastroenterol 2023)
  • AASLD 2017 — AASLD Practice Guidance on Portal Hypertensive Bleeding in Cirrhosis (Garcia-Tsao et al., Hepatology 2017/2024 update)
  • ESGE 2021 — European Society of Gastrointestinal Endoscopy guideline: diagnosis and management of non-variceal upper GI hemorrhage

Practice Gastrointestinal questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.